SGLT-2 Drug Makers Are Being More Forthcoming About Links To Fournier's Gangrene

Diabetes Drug Infection Lawsuit News

The risks of sodium-glucose blocker drugs Invokana, Jardiance, and Farixa may cause diabetic patients to think twice

Thursday, October 31, 2019 - Diabetics are required to inject themselves with insulin at times during the day to regulate their blood glucose (sugar) levels. Instead of that annoying inconvenience, patients may opt instead to take a sodium-glucose drug (SGLT-2) that routes excess sugar out of the body through the urine. SGST-2 drugs are effective but also carry exceedingly dangerous side effects that a doctor may not fully explain to a patient. Doctors make difficult and complex decisions for their patients, and do not debate what drug is right for them. Patients expect an experienced, credentialed doctor to use his or her education and experience to make decisions as to what drug is right for them. After all, that is what we're paying them for. A problem can arise, however, when a drug's side effects are so severe that the health of the patient is placed in jeopardy. The patient then wishes he/she had been told the truth in advance so that they could have made a better-informed decision and avoided the agony the drug has put them through. The following is just the beginning of what a diabetic patient needs to consider before taking sodium glucose blocker drugs. Diabetes drug infections lawyer offer a free consultation and no obligation to file a lawsuit claim.

SGLT-2 diabetes drugs Invokana, Jardiance, and Farixa's web sites all warn that taking the drug can result in severe dehydration resulting in dizziness and lightheartedness. Patients with low blood pressure or have kidney problems should consider SGLT2 drugs carefully as taking them can cause severe dehydration. Women who take the drug also run the risk of developing a vaginal yeast infection and men run the risk of developing a yeast infection of an uncircumcised penis. Such a condition is accompanied by an extremely foul-smelling discharge from the infected genital area.

SGLT-2 drugs have also been linked by the US Food and Drug Administration to a rare condition known as Fournier's Gangrene. Fournier's Gangrene is a form of necrotizing fasciitis, better known as the flesh-eating disease. Fournier's Gangrene is distinguishable from ordinary fasciitis because the condition affects the genitals of men and women causing them to blacken, stink and rot. Treatment for Fournier's Gangrene is amputation of the genitals followed by intravenous antibiotics.

The FDA reports 55 known cases of Fournier's Gangrene but the actual number could be many times greater. Most diabetic patients, their caregivers, and doctors have never heard of Fournier's Gangrene and often mistake the preventable condition for caregiver neglect. Florida nursing home patients may have died from what has been labeled a lack of proper care when in fact the patient's genital necrosis was due to taking an SGLT-2 drug for their diabetes. Astra Zeneca, maker of Farixa describes the drug's Fournier's Gangrene side effects by calling the condition: "rare but serious, life-threatening cases have been reported in patients receiving SGLT2 inhibitors including FARXIGA (Necrotizing Fasciitis of the Perineum (Fournier's Gangrene): Serious outcomes have included hospitalization, surgeries, and death. ... pain or tenderness, erythema, swelling in the genital or perineal area, along with fever or malaise."

More Recent Diabetes Drug Infection Lawsuit News:

Lawyers for Fournier's Gangrene

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.